Background {#Sec1}
==========

A brief history of medicine demonstrates the use of herbal medicine for the effective treatment of various ailments. Herbal medicine has been used since long in various forms including the decoction, powdered sample, oleoresins, crude extracts, fixed oil, essential oil etc \[[@CR1]\]. Various plants have been used in multiple types of food items for preservation and therapeutic effects \[[@CR2]\]. In this regards, essential oils have been manifested by several reporters to play a major role. Essential oils have the property to attenuate the effects of free radicals, e.g, reactive oxygen species (ROS) which are derived from metabolism of oxygen and exogenous agents \[[@CR3]\]. ROS are responsible for wide variety of diseased conditions including oxidative stress and nervous disorders \[[@CR4]\]. Essential oils are well-known for their radicals scavenging properties and amelioration of various cognitive disorders. Among the cognitive disorders, Alzheimer's disease (AD) is the most common in elderly people \[[@CR5]\]. One of the best therapeutic approaches for AD is to increase the concentration of the neurotransmitter (Acetylcholine) by inhibiting the enzyme (acetylcholinesterase) responsible for its breakdown. Various drugs originated either from natural or synthetic sources are being used for the management of AD and other nervous disorders \[[@CR6]\]. Similarly, it has also been reported that oxidative stress are responsible for wide variety of mental diseases due to neuronal degeneration and other factors. Oxidative stress is mainly developed due to increase in concentration of free radicals within the body. The free radicals have been reported by numerous researchers to possess multiple destructive properties, due to which interest has been focused to scavenge the free radicals somehow and avoid their deteriorating effects \[[@CR7]\]. In this context, investigators are trying to explore more and more sources of natural and synthetic bioactive principles \[[@CR8]\]. The natural drugs are being preferred over the synthetic due to their negligible harmful and deleterious effects \[[@CR9]\]. That's why researchers are trying to explore novel sources of natural medicine \[[@CR10]--[@CR18]\]. Among the natural sources, herbal medicines have been shown promising results due to the presence of numerous secondary metabolites and essential oils. Essential oils isolated from various plants have been reported to possess marked acetylcholinesterase inhibitory and radicals scavenging potential \[[@CR19]--[@CR21]\]. Traditional knowledge also demonstrates the use of essential oils for various nervous system disorders \[[@CR22]\].

*R. hastatus* D. Don belongs to the family Polygonaceae. Various members of this family have been reported to be used against paralysis, headache and other nervous system disorders \[[@CR23]--[@CR26]\]. Various solvent samples of *R. hastatus* have recently been reported to possess strong anticholinesterase and antioxidant potentials \[[@CR26]\]. To date, the chemical composition of essential oil of *R. hastatus* has not been reported or evaluated for any pharmacological activity. Based on the literature survey and medicinal importance of *R. hastatus*, the current investigational study is arranged to isolate the essential oil, analyze the chemical composition and to evaluate for the anticholinesterase and antioxidant potentials, which may be a possible remedy for oxidative stress and nervous system disorder.

Methods {#Sec2}
=======

Plant sample collection {#Sec3}
-----------------------

The aerial parts of *R. hastatus* were collected from the proximity of University of Malakand. The plant was identified by plant taxonomist Ali Hazrat and deposited with voucher number (1015SJ) in the herbarium of Department of Botany, Shaheed Benazir Bhutto University Sheringal, Dir (U), KPK, Pakistan. Extraction of essential oil of *R. hastatus* was performed by hydrodistillation using clevenger type apparatus \[[@CR27]\]. The essential oil obtained was stored at -20 °C until required.

Chemicals and drugs {#Sec4}
-------------------

DPPH (Sigma Aldrich CHEMIE GmbH USA, code 101341986), K~2~S~2~O~4~ (Riedel-de Haen Germany), ABTS (Sigma Aldrich USA, code 1001551916), Gallic acid (GmbH USA), Folin Ciocalteu reagent (Merck Co. Germany). AChE (Electric eel type-VI-S, Sigma-Aldrich GmbH USA, code 1001596210), BChE (Equine serum Lyophilized Sigma-Aldrich GmbH USA, code 101292670), Acetylthiocholine iodide (Sigma-Aldrich UK, code 101303874), Butyrylthiocholine Iodide (Sigma-Aldrich Switzerland, code 101334643), DTNB (Sigma-Aldrich Germany, code 101261619), Galanthamine hydrobromide Lycoris Sp. (Sigma-Aldrich France, code G1660). K~2~HPO~4~, KH~2~PO~4~, KOH. All the chemical used were of analytical grade.

Gas Chromatography (GC) analysis {#Sec5}
--------------------------------

The GC analysis of essential oil was carried out via gas chromatograph Agilent USB-393752 (Agilent Technologies, Palo Alto, CA, USA) with HHP-5MS 5 % phenylmethyl siloxane capillary column (30 m × 0.25 mm × 0.25 μm film thickness; Restek, Bellefonte, PA) connected with FID detector. The oven was set at temperature of 70 °C for one minute and then increased to 180 °C at the rate of 6 °C/min for 5 min and lastly to 280 °C at the rate of 5 °C/min for 20 min. The temperature of injector and detector were maintained at 220 °C and 290 °C correspondingly. The flow rate of carrier gas i.e., Helium was 1 ml/min and the diluted samples (1/1000 in *n*-pentane, v/v) of 1 μl were manually injected in the split-less mode.

Gas Chromatography--Mass Spectrometry (GC-MS) analysis {#Sec6}
------------------------------------------------------

The GC/MS of the essential oil was performed via USB-393752 gas chromatograph (Agilent Technologies, Palo Alto, CA, USA) with a HHP-5MS 5 % phenylmethyl siloxane capillary column (30 m × 0.25 mm × 0.25 μm film thickness; Restek, Bellefonte, PA) outfitted with an Agilent HP-5973 mass selective detector in the electron impact mode (Ionization energy: 70 eV) working under the experimental conditions as those maintained for GC.

Identification of components {#Sec7}
----------------------------

The recognition of all the major constituents of oil was performed by comparing their retention times with the authentic compounds in the literature. Identification of compounds was further processed through the spectral data obtained from the Wiley and NIST libraries as well as fragmentation patterns' comparisons of the mass spectra with data reported in literature or with those of mass spectra from literature \[[@CR28], [@CR29]\]. Each determination was processed in duplicate.

Anticholinesterase assays {#Sec8}
-------------------------

Anticholinesterase (AChE and BChE inhibitions) activity was performed for the essential oil of *R. hastatus* by spectrophotometric analysis following the method of Ellman\'s assay \[[@CR30]\]. The substrates used were acetylthiocholine iodide and butyrylthiocholine iodide. Briefly, 5 μL of 0.03 U/mL AChE and 0.01 U/mL BChE were taken in a cuvette and 205 μL of essential oil having concentration of 62.5--1000 μg/mL were transferred to them using micropipette. Similarly, 5 μLof DTNB was also added to this afterwards. The mixtures obtained were kept in water bath for 15 min at the temperature of 30 °C. After incubation, 5 μL of the Substrates were added to the mixture to optimize the reaction. A double beam spectrophotometer was used to measure the reaction time at 412 nm via a double beam spectrophotometer (Thermo electron corporation USA). Absorption values were obtained for 4 min. Meanwhile, the yellow colored mixtures indicated the formation of 5-thio-2-nitrobenzoate anion as a reaction product of thiocholines and DTNB. White assay was also performed without enzymes and plant samples to check the non-enzymatic hydrolysis of substrate. The mixture which contained all the components excluding essential oil was marked as control. Percent enzyme activity and percent inhibition were recorded as follows.$$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \mathrm{V} = \frac{\varDelta \mathrm{Abs}}{\varDelta \mathrm{t}} $$\end{document}$$$$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \%\ \mathrm{enzyme}\ \mathrm{activity} = \frac{\mathrm{V}}{{\mathrm{V}}_{\max }}\times 100 $$\end{document}$$$$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \%\ \mathrm{enzyme}\ \mathrm{inhibition}=100-\%\ \mathrm{enzyme}\ \mathrm{activity} $$\end{document}$$

(Where V symbolizes the rate of reaction in the presence of inhibitor and V~max~ stands for rate of reaction without inhibitor)

DPPH radical scavenging assay {#Sec9}
-----------------------------

The DPPH radical scavenging potential was evaluated for essential oil of *R. hastatus* following previously described procedure \[[@CR31]\]. DPPH solution (0.004 %) was prepared in methanol to get a deep violet colored solution. Similarly, stock solution of essential oil was prepared in ethanol having concentration of 1 mg/mL. The stock solution was serially diluted to get the concentrations of 62.5 to 1000 μg/mL. Afterwards, 0.1 mL of each concentration was added to the 3 mL of DPPH solution. The mixture obtained was incubated at 23 °C for 30 min in dark. After incubation the absorbance of each sample were recorded at the wavelength of 517 nm using double beam spectrophotometer. Ascorbic acid was used as positive control. All the samples were processed in triplicates and the percent activity was recorded as mean ± SEM. The percent radical scavenging potential was figured out using the following formula;$$\documentclass[12pt]{minimal}
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ABTS radical scavenging assay {#Sec10}
-----------------------------

The 2, 2-azinobis \[3-ethylbenzthiazoline\]-6-sulfonic acid (ABTS) free radicals scavenging assay of the essential oil was evaluated followed standard procedure \[[@CR11]\]. ABTS solution 7 mM and potassium persulfate solution 2.45 mM were prepared and mixed thoroughly. The solution prepared was put in dark overnight for the production of free radicals. After incubation time the absorbance of solution was adjusted at 745 nm to 0.7 by the addition of 50 % methanol. Test samples having volume of 300 μl was taken in a test tube and 3 mL ABTS solution was added to it. The solution was transferred to the cuvette and absorbance values were taken for six minutes using double beam spectrophotometer. Ascorbic acid was used as positive control. All the samples were run in triplicate and percent ABTS radical scavenging potential was figured out using the following formula;$$\documentclass[12pt]{minimal}
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Estimation of IC~50~ values {#Sec11}
---------------------------

The median inhibitory concentration i.e., IC~50~ values of AChE, BChE, DPPH and ABTS were determined by a linear regression analysis of the percent inhibition versus the concentrations of test samples through MS Excel program.

Statistical data analysis {#Sec12}
-------------------------

All the tests were conducted in triplicate and the values were tabulated as mean ± S.E.M. Significant difference of the percent inhibition of various test samples was analyzed via two way ANOVA following Bonferroni's post test using GraphPad Prism software in which the *P* \< 0.05 were considered significant.

Results and discussion {#Sec13}
======================

In the current investigational study the radical scavenging potential of volatile oil was studied based on spectrophotometric analysis. The sources of free radicals employed were DPPH and ABTS, which have maximum absorbance values at 517 nm and 745 nm respectively. After getting scavenged by antioxidant compounds the colors of DPPH (violet) and ABTS (blue) solution change into yellow. Change in the color results in decrease of absorbance values which is directly proportional to the amount of radical scavenging compounds in the solution \[[@CR32], [@CR33]\].

Similarly, the anticholinesterase activity is based on the hydrolysis of acetylthiocholine iodide and butyrylcholine iodide by the formation of the yellow 5-thio-2- nitrobenzoate anion as a result of the reaction of DTNB with thiocholines, catalyzed by enzymes at a wavelength of 412 nm using spectrophotometer or microplate reader. Acetylthiocholine iodide and butyrylthiocholine iodide work as substrate of the reaction, while the DTNB is utilized for the measurement of cholinesterase activity. The percent inhibition of enzymatic activity is calculated from the rate of change in absorption of the reaction mixture \[[@CR34]\].

The available literature on etiology of diseases demonstrate multiple causative agents responsible for specific disease \[[@CR35]\]. In the context of Alzheimer's disease, numerous investigators have reported the role of various causative agents along with various successful approaches \[[@CR36]\]. Like all neurodegenerative disorders, the free radicals have a prominent role in the induction and progression of AD \[[@CR37]\]. By avoiding or attenuating the causative agents one can hinder the progression of a specific disease. In case of neurodegenerative disorders, the scavenging of free radicals can be a vital target. Various researchers have demonstrated the effective role of natural antioxidants especially the essential oils to combat the free radicals \[[@CR38]\]. Similarly, one of the most widely employed treatment strategies for AD i.e., the inhibition of AChE to increase the concentration of neurotransmitter is highly recommended \[[@CR39]\]. In this regard, essential oils are being investigated by advanced researchers with better results. Essential oils obtained from various plants possess marked anti-Alzheimer's potential due to the presence of wide variety of valuable compounds in it \[[@CR40], [@CR41]\]. The anticholinesterase potential of essential oil of *Rumex hastatus* has been summarized in the Table [1](#Tab1){ref-type="table"}, while the Table [2](#Tab2){ref-type="table"} shows various parameters of the compounds present in the essential oil of this plant. The GC-MS analysis of essential oil of *R. hastatus* demonstrates a total of 123 components as shown in Table [3](#Tab3){ref-type="table"}. The anticholinesterase activity of essential oil of *R. hastatus* might be due to its hydrophobic nature because of the good affinity of hydrophobic active site of AChE \[[@CR42], [@CR43]\]. Some of the most common components of essential oils i.e., palmitic acid, myristic acid, pelargic acid, capric acid, docosane, cetane, velleral, acetone, methyl palmitate, widdrol, isolongifolol, ophytadiene, drimenol and levulinic acid have been found in the essential oil of *R. hastatus*. Some of these components have been reported previously by other investigators to possess antioxidant and anticholinesterase potentials \[[@CR44]--[@CR49]\]. The percent antioxidant potential of essential oil is illustrated in the Fig. [1](#Fig1){ref-type="fig"}. The peaks given in the Table [2](#Tab2){ref-type="table"} shows various volatile compounds like 5-ethyl-2(5H)-furanone, trimethylacetic anhydride, cyclooctanone, 5-methyl-3-heptanol, methyl 2-vinylbutanoate, 2-(*p*-methylphenyl)-2-nitropropne, azelaaldehydic acid, 2,4,6-trimethyloctane and *trans*-3-nonen-2-one with retention times of 6.447, 6.818, 10.958, 11.363, 11.761, 12.97, 13.171, 13.308, 15.063 and 19.213 min respectively. Going to the detail of various components of essential oil of *R. hastatus*, it is clear that the marked anticholinesterase potential shown by essential oil is observed due to the presence of wide variety of compounds in it. Essential oil demonstrated 74.90, 71.70, 67.26, 61.64, 54.32 % AChE inhibition at 1000, 500, 250, 125, 62.5 μg/ml respectively. Similarly, the BChE inhibition exhibited by essential oil was recorded as 71.32, 66.33, 46.32, 52.73, 57.00 % at 1000, 500, 250, 125, 62.5 μg/ml respectively. The essential oil attain IC~50~ values of 32.54 and 97.38 μg/ml for AChE and BChE inhibitions respectively. The anticholinesterase potential shown by essential oil goes parallel with the positive control which is also obvious from the Fig. [2](#Fig2){ref-type="fig"} ([a](#Fig2){ref-type="fig"} & [b](#Fig2){ref-type="fig"}) with the correlation coefficient of 0.961 and 0.988 for essential oil versus AChE and BChE respectively. Apart from the anticholinesterase potential of essential oil, the antioxidant potential of essential oil of various plants has been reported with discrimination by various investigators \[[@CR50], [@CR51]\]. In our current investigational study, the free radicals scavenging assay of essential oil of *R. hastatus* against DPPH and ABTS was significant and almost comparable with the positive control. From Fig. [1](#Fig1){ref-type="fig"}, it is clear that essential oil exhibited marked potential with IC~50~ of 3.71 and 6.29 μg/ml against DPPH and ABTS respectively, which is also comparable with the previously reported literature. The previously reported data of *R. hastatus* verifies its anticholinesterase and antioxidant potentials which may be linked to the current investigational studies \[[@CR26]\].Table 1Anticholinesterase activity of essential oil of *Rumex hastatus* at various concentrationsSamplesEnzymesConc. μg/mlConc. μg/mlConc. μg/mlConc. μg/mlConc. μg/mlIC~50~ μg/ml62.51252505001000EOAChE54.32 ± 1.3361.64 ± 1.6067.26 ± 1.2471.70 ± 1.6374.90 ± 0.5232.54EOBChE46.32 ± 3.5052.73 ± 0.7857.00 ± 2.8066.33 ± 0.4971.32 ± 4.897.38GalAChE72.08 ± 1.0478.58 ± 1.1283.70 ± 1.6089.00 ± 1.1596.65 ± 1.3404.73GalBChE66.87 ± 1.2773.67 ± 0.8879.95 ± 2.0186.62 ± 1.6791.61 ± 0.4311.09Data is expressed as Mean ± SEM; EO and Gal are abbreviated for Essential oil and Galanthamine respectivelyTable 2Parameters of various components of essential oil of *Rumex hastatus*RT (min)HeightHeight (%)AreaArea (%)Area Sum %Base Peak m/zWidth6.44725441318.5162005720.825.87830.1276.81832411023.5962604521.025.9357.10.07710.95843095831.3682252927.617.7955.10.07411.36325014318.259269719.95.6159.10.0911.76127805820.2366576122.356.3159.10.09412.9717706012.8839979213.423.7943.10.09713.17131284122.7766448722.316.2955.10.0813.3081E + 061003E + 0610028.2157.10.115.06315979011.6333686111.313.1955.10.0819.21345035632.7778208326.267.41133.10.064Table 3List of components of essential oil of *Rumexhastatus*S.NoCompound LabelCommon nameRTFormulaHits (DB)1.Trans-dideuterioxy-cyclopenteneNF5.757C5H6D2O2102.1-Nonen-4-olNF5.884C9H18O103.Ethyl 2-hydroxybutyrateNF6.169C6H12O3104.2(5H)-Furanone, 5-ethylNF6.445C6H8O2105.Pentanoic acid, 4-oxoLevulinic acid6.68C5H8O3106.2,2-Dimethylpropanoic anhydrideTrimethylacetic anhydride6.819C10H18O3107.Heptanoic acidEnanthic acid7.117C7H14O2108.Ethanethioic acid, S-(2-methylpropyl) esterNF7.374C6H12OS109.4-Octanol, 7-methylNF7.511C9H20O1010.4-(Tetrahydrofuranyl-2-oxy)-4-methyl-2-pentanoneNF7.619C10H18O31011.Cyclopropane, 1,2-dimethyl-1-pentylNF7.698C10H201012.n-NonanalNonanal7.852C9H18O1013.CyclooctanoneNF8.275C8H14O1014.1,4,4-Trimethylcyclohexa-2-en-1-olNF8.494C9H16O1015.3-Octanol, 2-methylNF8.716C9H20O1016.2-Oxatricyclo\[3.3.1.1(3,7)\]decane, 1-methyl-NF9.116C10H16O1017.Succinimide, N-methoxyNF9.338C5H7NO31018.4-Heptanol, 2-methylNF9.547C8H18O1019.Ethanone, 1-(methylphenyl)Methylacetophenone9.712C9H10O1020.DecanalNF10.099C10H20O1021.3-Heptanol, 2,4-dimethylNF10.328C9H20O1022.CyclooctanoneNF10.957C8H14O1023.1-Decyne (CAS) \$\$ OctylacetyleneNF11.165C10H181024.3-Heptanol, 5-methylNF11.364C8H18O1025.Nonanoic acidPelargic acid11.456C9H18O21026.ETHYL AMYL CARBINOLNF11.763C8H18O1027.CIS-SABINENE HYDRATENF11.96C10H18O1028.1,8-BisoxiranylnonaneNF12.047C13H24O21029.3-Heptanone, 4-methylNF12.817C8H16O1030.Methyl 2-vinylbutanoateNF12.972C7H12O21031.trans-3-Nonen-2-oneNF13.171C9H16O1032.Octane, 2,4,6-trimethylNF13.309C11H241033.2H-Pyran-2-one, 6-heptyltetrahydroDelta.-laurolactone13.471C12H22O21034.Decanoic acidCapric acid13.601C10H20O21035.3-OctanolNF14.002C10H22O1036.Ethyl 3,3-dimethylbutyrateNF14.246C8H16O2137.5-HexenalNF14.547C6H10O1038.2-Pentenoic acid, 4-hydroxyNF14.878C5H8O31039.Nonanoic acid, 9-oxo-, methyl esterAzelaadehydic acid15.065C10H18O31040.Thiophene, 2-methoxyNF15.345C5H6OS341.Octanoic acid, 8-hydroxyNF15.49C8H16O31042.Oxirane, octylNF15.604C10H20O1043.Butane, 1,1\'-oxybis\[3-methylNF15.875C10H22O544.3-Hydroxy-4-methoxystyreneNF16.153C9H10O2745.Octanoic Acidn-Caprylic acid16.355C8H16O21046.3-Hexanol, 3,5-dimethylNF16.55C8H18O1047.2-Tridecen-1-ol, (E)NF16.643C13H26O1048.1-Isopropyl-4,7-dimethyl-1,2-dihydronaphthaleneAlpha-Calcorene16.877C15H201049.4-(5\',5\'-dimethyl-2\'-methylidene-3\',8\'-dioxabicyclo\[5.1.0\]oct-4-ylidene)-2-b...NF17.084C13H18O3550.9-Methyl-S-octahydrophenanathraceneNF17.192C15H201051.Z-10-Tetradecen-1-ol acetateNF17.373C16H30O21052.Dodecanamide, N,N-bis(2-hydroxyethyl)NF17.737C16H33NO31053.5,8-Dimethyl-1,2,3,4-tetrahydro-1-naphtholNF17.847C12H16O354.3-Hexen-1-ol, benzoate, (Z)NF17.917C13H16O21055.Nonanoic acidPelargic acid18.014C9H18O21056.Nonanedioic acid, monomethyl esterNF18.153C10H18O41057.(-)-Caryophyllene oxideCaryophyllene oxide18.311C15H24O1058.(+-)-AndirolactoneAndirolactone18.513C11H14O21059.LedolNF18.64C15H26O1060.(. + -.)-2-Methyl-6-p-tolyl-4-heptanol (diastereoisomer II)NF18.693C15H24O961.Propanal, 2,2-dimethylNF18.777C5H10O162.2,6,10-Trimethylundecan-(5E)-2,5,9-trien-4-oneNF18.869C14H22O1063.7-oxabicyclo\[4.1.0\]heptane, 1-(1,3-dimethyl-1,3-butadienyl)-2,2,6-trimethyl-NF19.004C15H24O1064.Octanoic acid, 6,6-dimethoxy-, methyl esterNF19.087C11H22O41065.2-(p-methylphenyl)-2-nitropropaneNF19.212C10H13NO21066.Azelaic AcidAnchoic acid19.589C9H16O4467.cis-9-oxabicyclo\[6.1.0\]non-2-eneNF19.736C8H12O1068.1-Buten-3-one, 1-(2-carboxy-4,4-dimethylcyclobutenyl)NF19.864C11H14O31069.CampherenoneCampherenone20.056C15H24O1070.11-Hexadecyn-1-olNF20.231C16H30O1071.Cyclodecene, 1-ethyl-2-methyl-NF20.385C13H241072.1,3-Dioxolane-4,5-dicarboxylic acid, 2,2-dimethyl-, dimethyl esterNF20.627C9H14O6573.10-(1-Methylallyl)tricyclo\[6.3.1.0(2,7)\]dodeca-2(7),3,5-trien-10-olNF20.768C16H20O474.2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalinNF20.894C15H24O41075.Farnesyl Acetone CFarnesyl Acetone21.18C18H30O1076.17-Octadecynoic acidNF21.401C18H32O21077.Tetradecanoic acidMyristic acid21.82C14H28O21078.DriminolDrimenol22.167C15H26O1079.2,2,6-Trimethyl-1-(3-methylbuta-1,3-dienyl)-7-oxabicyclo\[4.1.0\]heptan-3-olNF22.272C14H22O21080.1,3,5-trimethyl-6-methyliden-tricyclo\[3.2.1.0(2,7)\]oct-3-en-8-endo-olNF22.677C12H16O981.1-Methyl-2-acetyl-6-methoxy-3,4-dihydronaphthaleneNF22.933C14H16O21082.N-(1-Cyanoethyl)(7,7-dimethyl-2-oxobicyclo\[2.2.1\]hept-1-ylmethanesulfonamideNF23.386C13H20N2O3S1083.5-(ethylamino)-1,6-dimethyl-2(1H)-quinolinoneNF23.511C13H16N2O1084.(-)-IsolongifololIsolongifolol23.926C15H26O1085.NeophytadieneNeophytadiene24.02C20H381086.Naphthalene, 1-(1,1-dimethylethyl)-7-methoxy-NF24.123C15H18O287.2-Pentadecanone, 6,10,14-trimethylNF24.218C18H36O1088.2,5,8-Trimethyltricyclo\[5.3.1.1(3,9)\]dodecane-2-anti,8-tnti-diolNF24.561C15H26O2389.Pentadecanoic acidPentadecyclic acid24.74C15H30O21090.9,19-Cycloergost-24(28)-en-3-ol, 4,14-dimethyl-, acetateNF25.047C32H52O2491.8-Keto-10-dehydrobrominated-.beta.-snyderolNF25.298C15H22O2292.WiddrolWiddrol25.848C15H26O1093.2,4,7,9-Tetramethyl-5-decyne-4,7-diolNF26.036C14H26O2494.Phenol, 2-methyl-4-(1,1,3,3-tetramethylbutyl)NF26.54C15H24O1095.Benzene, 1,1\'-(1,2-diethyl-1,2-ethanediyl)bis\[4-methoxy-NF26.548C20H26O21096.(1R,3S)-2,2,3-Trimethyl-6-methylidenecyclohexane-1-carbaldehydeNF26.624C11H18O597.Hexadecanoic acid, methyl esterMethyl palmitate26.732C17H34O21098.1-Hexadecen-3-ol, 3,5,11,15-tetramethyl-NF27.371C20H40O1099.Benzo\[e\]isobenzofuran-1,4-dione,1,3,4,5,5a,6,7,8,9,9a-decahydro-6,6,9a-trime...NF27.585C15H20O310100.Hexadecanoic acidPalmitic acid27.984C16H32O210101.Butane-1,1-dicarbonitrile, 1-cyclohexyl-3-methyl-NF28.431C13H20N210102.2-Methyl-2-propyl-2,5-dihydrofuranNF28.552C8H14O10103.5A-Methyl-3,8-dimethylene-2-oxododecahydrooxireno\[2\',3\':6,7\]naphtho\[1,2-b\]fu...NF28.643C20H24O510104.4-(3,7,7-Trimethyl-2-oxabicyclo\[3.2.0\]hept-3-en-1-yl)but-3-en-2-oneNF28.98C13H18O210105.Cyclobutanecarboxylic acid, 2-methyloct-5-yn-4-yl esterNF29.064C14H22O210106.Cyclooctenone, dimerNF29.439C16H24O210107.Undecane, 6-cyclohexyl-NF29.639C17H3410108.2,4,5,7-Tetramethyl-2,6-octadieneNF30.471C12H2210109.Cyclohexane, 1,2,3,4,5,6-hexaethylNF30.77C18H3610110.Cyclopentanone, 3-methyl-2-(2-pentenyl)-NF31.291C11H18O10111.2-PropanonAcetone31.44C3H6O10112.beta.-Ionol \$\$ 3-Buten-2-ol, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-NF31.703C13H22O10113.VelleralVelleral32.121C15H20O210114.2-Hydrazino-2-imidazolineNF32.733C3H8N410115.2H-cyclopropa\[g\]benzofuran, 4,5,5A,6,6A,6B-hexahydro-4,4,6b-trimethyl-2-(1-m...NF33.658C15H22O10116.HexadecaneCetane37.132C16H3410117.DocosaneDocosane38.808C22H4610118.4,4-6-Trimethyl-7-oxabicyclo\[4.1.0\]heptan-2-oneNF39.247C9H14O210119.1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) esterNF39.623C24H38O410120.4-Allyl-1-ethoxy-3-phenylbenzo\[c\]-(1,2)-oxaphosphinine - 1-OxideNF40.4C19H19O3P3121.HexadecaneCetane41.915C16H3410122.Undecane, 3,8-dimethyl-NF44.76C13H2810123.4-Methyl-7-ethylizidine \$\$ 8-Methyl-5-ethylindolizidineNF58.237C11H21N10Fig. 1Antioxidant potential of essential of *Rumex hastatus* against DPPH and ABTSFig. 2**a.** Regression and correlation of percent BChE inhibition of essential oil Vs Galanthamine. **b.** Regression and correlation of percent AChE inhibition of essential oil Vs GalanthamineFig. 3Structures of some important components of essential oil of *Rumex hastatus*Fig. 4GC-MS Chromatogram of essential oil of *Rumex hastatus* Some important components of essential oil and the chromatogram have been given in Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"} respectively.

Conclusion {#Sec14}
==========

Essential oil isolated for the first time from the *R. hastatus* and its chemical composition demonstrates that *R. hastatus* is a source of valuable volatile components. Based on the anticholinesterase and antioxidant results of essential oil, it can be concluded that *R. hastatus* plant may be an effective source of compounds which may lead to possible palliative therapy and cure of oxidative stresses and neurodegenerative diseases.
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